This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, B.-C. Articles by Avraham, H. K. Search for Related Content PubMed PubMed Citation Articles by Lee, B.-C. Articles by Avraham, H. K.

Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1)–Mediated Breast Cancer Cell Migration

Divisions of ¹ Experimental Medicine and ² Endocrinology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Hava Karsenty Avraham, Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 4 Blackfan Circle, 3rd Floor, Boston, MA 02115. Phone: 617-667-0073; Fax: 617-975-6373; E-mail: havraham{at}bidmc.harvard.edu.

Using microarray gene analysis, we found that carboxyl-terminal Src kinase homologous kinase (CHK) regulated the expression of the chemokine receptor, CXCR4. Northern blot and fluorescence-activated cell-sorting analyses showed that CHK down-regulated CXCR4 mRNA and protein levels, respectively. Mutated CHK, which contains a mutation within the ATP binding site of CHK, failed to inhibit CXCR4 expression, thus suggesting that CHK kinase activity is involved in the regulation of CXCR4. Results from gel shift analysis indicated that CHK regulates CXCR4 transcriptional activity by altering YY1 binding to the CXCR4 promoter. Whereas CHK had no significant effects on the expression of YY1, c-Myc, Max, and other YY1-binding proteins, CHK was found to modulate the YY1/c-Myc association. Furthermore, CHK inhibited CXCR4-positive breast cancer cell migration. Taken together, these studies show a novel mechanism by which CHK down-regulates CXCR4 through the YY1 transcription factor, leading to decreased CXCR4-mediated breast cancer cell motility and migration.

Key Words: YY1 • CXCR4 • breast cancer • CHK • migration • Genitourinary cancers: prostate

This article has been cited by other articles:

				R. L. Prentice, Y. Huang, D. A. Hinds, U. Peters, M. Pettinger, D. R. Cox, E. Beilharz, R. T. Chlebowski, J. E. Rossouw, B. Caan, et al. Variation in the FGFR2 Gene and the Effects of Postmenopausal Hormone Therapy on Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3079 - 3085. [Abstract] [Full Text] [PDF]

				R. Marlow, P. Strickland, J. S. Lee, X. Wu, M. PeBenito, M. Binnewies, E. K. Le, A. Moran, H. Macias, R. D. Cardiff, et al. SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium Cancer Res., October 1, 2008; 68(19): 7819 - 7827. [Abstract] [Full Text] [PDF]

				F. de Nigris, R. Rossiello, C. Schiano, C. Arra, S. Williams-Ignarro, A. Barbieri, A. Lanza, A. Balestrieri, M. T. Giuliano, L. J. Ignarro, et al. Deletion of Yin Yang 1 Protein in Osteosarcoma Cells on Cell Invasion and CXCR4/Angiogenesis and Metastasis Cancer Res., March 15, 2008; 68(6): 1797 - 1808. [Abstract] [Full Text] [PDF]

				M. De La Luz Sierra, P. Gasperini, P. J. McCormick, J. Zhu, and G. Tosato Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells Blood, October 1, 2007; 110(7): 2276 - 2285. [Abstract] [Full Text] [PDF]

				B.-C. Lee, S. Avraham, A. Imamoto, and H. K. Avraham Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice Blood, August 1, 2006; 108(3): 904 - 907. [Abstract] [Full Text] [PDF]